Morgan Stanley »

Akero Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 947k 23.46
2024-03-31 $10M 404k 25.26
2023-12-31 $25M 1.1M 23.35
2023-09-30 $22M 440k 50.58
2023-06-30 $18M 386k 46.69
2022-12-31 $11M 207k 54.80
2022-06-30 $0 139k 0.00
2022-03-31 $2.4M 167k 14.18
2021-06-30 $2.2M 90k 24.62
2020-12-31 $743k 29k 25.80
2020-09-30 $219k 7.1k 30.92
2020-06-30 $3.4M 136k 24.87
2020-03-31 $28k 1.3k 21.60
2019-12-31 $148k 6.7k 22.24
2019-09-30 $38k 1.7k 22.98